Class information for:
Level 1: SUNITINIB//METASTATIC RENAL CELL CARCINOMA//RENAL CELL CARCINOMA

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
417 3       RENAL CELL CARCINOMA//ANGIOMYOLIPOMA//PARTIAL NEPHRECTOMY 30583
523 2             RENAL CELL CARCINOMA//PARTIAL NEPHRECTOMY//KIDNEY NEOPLASMS 15437
747 1                   SUNITINIB//METASTATIC RENAL CELL CARCINOMA//RENAL CELL CARCINOMA 3129

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 SUNITINIB authKW 2648763 20% 42% 633
2 METASTATIC RENAL CELL CARCINOMA authKW 1687234 8% 66% 252
3 RENAL CELL CARCINOMA authKW 1372194 33% 13% 1017
4 AXITINIB authKW 637913 4% 57% 112
5 SORAFENIB authKW 616404 11% 17% 355
6 TEMSIROLIMUS authKW 535288 4% 39% 137
7 PAZOPANIB authKW 504285 4% 39% 127
8 CYTOREDUCTIVE NEPHRECTOMY authKW 370747 2% 78% 47
9 RENAL CELL CANCER authKW 273428 4% 20% 133
10 TARGETED THERAPY authKW 235296 11% 7% 356

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 45616 62% 0% 1941
2 Urology & Nephrology 24449 26% 0% 813
3 Pharmacology & Pharmacy 910 12% 0% 385
4 Medicine, Research & Experimental 31 2% 0% 77
5 Medicine, General & Internal 22 3% 0% 97
6 Health Care Sciences & Services 20 1% 0% 31
7 Peripheral Vascular Diseases 13 1% 0% 44
8 Hematology 5 1% 0% 39
9 Health Policy & Services 1 0% 0% 12
10 Toxicology 0 1% 0% 30

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 SOLID TUMOR ONCOL 135572 3% 15% 92
2 TAUSSIG CANC 113575 4% 8% 140
3 SOLID TUMOR ONCOL UROL 94401 0% 63% 15
4 MED ONCOL 81756 20% 1% 636
5 KIDNEY CANC 73092 0% 52% 14
6 CLIN HEMATOL HEMOSTASIS ONCOL STEM CELL TRANSPL 65906 0% 55% 12
7 GENITOURINARY ONCOL SERV 54768 2% 11% 48
8 UROL 54012 25% 1% 790
9 MED ONCOL EXPT THER EUT 53180 1% 22% 24
10 KIDNEY CANC PROGRAM 46978 0% 33% 14

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CLINICAL GENITOURINARY CANCER 223310 4% 17% 132
2 TARGETED ONCOLOGY 32246 1% 8% 38
3 EXPERT REVIEW OF ANTICANCER THERAPY 21758 2% 4% 61
4 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 21708 2% 3% 66
5 EUROPEAN UROLOGY SUPPLEMENTS 12371 1% 5% 27
6 ANNALS OF ONCOLOGY 10832 3% 1% 96
7 FUTURE ONCOLOGY 10166 1% 3% 40
8 EUROPEAN UROLOGY 7630 2% 1% 75
9 ONCOLOGIST 6861 1% 2% 40
10 UROLOGE 6777 1% 2% 36

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 SUNITINIB 2648763 20% 42% 633 Search SUNITINIB Search SUNITINIB
2 METASTATIC RENAL CELL CARCINOMA 1687234 8% 66% 252 Search METASTATIC+RENAL+CELL+CARCINOMA Search METASTATIC+RENAL+CELL+CARCINOMA
3 RENAL CELL CARCINOMA 1372194 33% 13% 1017 Search RENAL+CELL+CARCINOMA Search RENAL+CELL+CARCINOMA
4 AXITINIB 637913 4% 57% 112 Search AXITINIB Search AXITINIB
5 SORAFENIB 616404 11% 17% 355 Search SORAFENIB Search SORAFENIB
6 TEMSIROLIMUS 535288 4% 39% 137 Search TEMSIROLIMUS Search TEMSIROLIMUS
7 PAZOPANIB 504285 4% 39% 127 Search PAZOPANIB Search PAZOPANIB
8 CYTOREDUCTIVE NEPHRECTOMY 370747 2% 78% 47 Search CYTOREDUCTIVE+NEPHRECTOMY Search CYTOREDUCTIVE+NEPHRECTOMY
9 RENAL CELL CANCER 273428 4% 20% 133 Search RENAL+CELL+CANCER Search RENAL+CELL+CANCER
10 TARGETED THERAPY 235296 11% 7% 356 Search TARGETED+THERAPY Search TARGETED+THERAPY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 6478 RENAL CELL CARCINOMA//CARCINOMA RENAL CELL//RENAL CELL
2 7485 VANDETANIB//RAMUCIRUMAB//CEDIRANIB
3 29828 REGORAFENIB//FRUQUINTINIB//N DESETHYL SUNITINIB
4 17263 BEVACIZUMAB//METASTATIC BREAST CANCER//HER2 NEGATIVE
5 20961 RECIST//RECIST 11//TARGET LESION
6 27542 TEROXIRONE//CHEMOENDOCRINE TREATMENT//DOSE ASSESMENT
7 18187 KIDNEY CANCER//SERV INTEGRATO EPIDEMIOL SISTEMI INFORMAT//RENAL CELL CARCINOMA
8 36401 BIOL PHARM CLIN//ACCELERATED APPROVAL REGULATIONS//AG 1295
9 26425 BAP1//SETD2//PBRM1
10 19116 PANCREATIC METASTASIS//PANCREATIC METASTASES//GALLBLADDER METASTASIS

Go to start page